Zobrazeno 1 - 10
of 12
pro vyhledávání: '"R T, Davey"'
Autor:
K J, Cortez, M A, Proschan, L, Barrett, D G, Brust, Barry, Weatherley, E, Formentini, R T, Davey, H, Masur, M A, Polis, A U, Neumann And, S, Kottilil
Publikováno v:
HIV Clinical Trials. 14:149-159
Coinfection with HIV and hepatitis B virus (HBV) substantially alters the course of HBV. Directly acting anti-HBV agents suppress HBV viral levels; however, the kinetics of HBV decline in mono- and coinfected persons have not been evaluated. We inves
Autor:
M J Boyle, M Connors, M E Flanigan, S P Geiger, H Ford, M Baseler, J Adelsberger, R T Davey, H C Lane
Publikováno v:
The Journal of Immunology. 154:6612-6623
PBL from HIV-infected patients were engrafted into CB-17 SCID mice to develop a novel small animal model for the study of HIV pathogenesis and therapy. Engraftment was achieved in 84% of mice, with human Ig (hu-Ig) levels and total human mononuclear
Publikováno v:
Scopus-Elsevier
Angiogenin is a 14.4-kDa human plasma protein with 65% homology to RNase A that retains the key active site residues and three of the four RNase A disulfide bonds. We demonstrate that recombinant angiogenin functions as a cytotoxic tRNA-specific RNas
Autor:
S Koenig, T R Fuerst, L V Wood, R M Woods, J A Suzich, G M Jones, V F de la Cruz, R T Davey, S Venkatesan, B Moss
Publikováno v:
The Journal of Immunology. 145:127-135
Epitope mapping of a MHC class I-restricted cytotoxic T cell response to nef, a regulatory protein of HIV, was performed with fresh PBMC from HIV-seropositive donors and target cells pulsed with a panel of overlapping peptides of the nef protein. The
Autor:
J A, Kovacs, S, Vogel, J A, Metcalf, M, Baseler, R, Stevens, J, Adelsberger, R, Lempicki, R L, Hengel, I, Sereti, L, Lambert, R L, Dewar, R T, Davey, R E, Walker, J, Falloon, M A, Polis, H, Masur, H C, Lane
Publikováno v:
European journal of immunology. 31(5)
To characterize the immunological effects of intermittent IL-2 therapy, which leads to selective increases in CD4+ T lymphocytes in HIV-infected patients, 11 patients underwent extensive immunological evaluation. While IL-2 induced changes in both CD
Publikováno v:
Pharmacotherapy. 16(5)
To assess the pharmacokinetics and pharmacodynamics of subcutaneously administered interleukin-2 (IL-2) in patients infected with the human immunodeficiency virus (HIV).Open, dose-escalating phase I clinical trial.Government research hospital.Eightee
Autor:
M J, Boyle, M, Connors, M E, Flanigan, S P, Geiger, H, Ford, M, Baseler, J, Adelsberger, R T, Davey, H C, Lane
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 154(12)
PBL from HIV-infected patients were engrafted into CB-17 SCID mice to develop a novel small animal model for the study of HIV pathogenesis and therapy. Engraftment was achieved in 84% of mice, with human Ig (hu-Ig) levels and total human mononuclear
Publikováno v:
Archives of dermatology. 131(3)
Publikováno v:
The Journal of biological chemistry. 267(30)
Angiogenin is a 14.4-kDa human plasma protein with 65% homology to RNase A that retains the key active site residues and three of the four RNase A disulfide bonds. We demonstrate that recombinant angiogenin functions as a cytotoxic tRNA-specific RNas
Autor:
S, Koenig, T R, Fuerst, L V, Wood, R M, Woods, J A, Suzich, G M, Jones, V F, de la Cruz, R T, Davey, S, Venkatesan, B, Moss
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 145(1)
Epitope mapping of a MHC class I-restricted cytotoxic T cell response to nef, a regulatory protein of HIV, was performed with fresh PBMC from HIV-seropositive donors and target cells pulsed with a panel of overlapping peptides of the nef protein. The